{
  "name": "Vertex Pharmaceuticals",
  "slug": "vertex-pharmaceuticals",
  "ticker": "VRTX",
  "fetched_at": "2025-09-04T12:22:20.631865+00:00",
  "news": [
    {
      "title": "Relative strength of Vertex Pharmaceuticals Incorporated in sector analysis - Earnings Recap Summary & Daily Entry Point Alerts - Newser",
      "link": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNWnYzdHM3OS1DeUVkbzVNUjNKNDRLa3g0M1NIdk5SLWlsaTloS3E0Mll4U3hnUEt1S0VBRnZvUGxSek1aRHdXMUhfcFVoUHkwUDhLNXc2aldPSkFkMnQtbTR4VDJ3SHF5RGFsM3QtNmgwb1FDUnVrczAtRHJLLTk0TE5aMGtoV2dBR1JfNm5DTmxZLXFRLWMtWmw0dWFCSko4MWtGb015Y0t0X010U1E?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMirgFBVV95cUxNWnYzdHM3OS1DeUVkbzVNUjNKNDRLa3g0M1NIdk5SLWlsaTloS3E0Mll4U3hnUEt1S0VBRnZvUGxSek1aRHdXMUhfcFVoUHkwUDhLNXc2aldPSkFkMnQtbTR4VDJ3SHF5RGFsM3QtNmgwb1FDUnVrczAtRHJLLTk0TE5aMGtoV2dBR1JfNm5DTmxZLXFRLWMtWmw0dWFCSko4MWtGb015Y0t0X010U1E?oc=5\" target=\"_blank\">Relative strength of Vertex Pharmaceuticals Incorporated in sector analysis - Earnings Recap Summary & Daily Entry Point Alerts</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Newser</font>",
      "published": "2025-09-04T08:51:15+00:00",
      "source": "Newser"
    },
    {
      "title": "Enlaza Therapeutics Forms $2.4 Billion Collaboration with Vertex Pharmaceuticals - PharmExec",
      "link": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxOb0JfakZLeGZIazVnZHYzNjZ2UGJpME5DRUxtS1F0d09HZWVOMFhwQkhxMmRpbFh2T2IxSjQwZDZfTHdNNnlDNTZmN0ppeU5abUtoVW5TbGtRVTVaY3RmTHNjWFBIbWtJVXlPOUtzRHZEbXRfM2ducE1TMGRTX0dGMUtuM05EeERPb2p3U0N5OHhzaktTaTQxRTlUc1hncEtzYUZZUUI2SnY?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiqAFBVV95cUxOb0JfakZLeGZIazVnZHYzNjZ2UGJpME5DRUxtS1F0d09HZWVOMFhwQkhxMmRpbFh2T2IxSjQwZDZfTHdNNnlDNTZmN0ppeU5abUtoVW5TbGtRVTVaY3RmTHNjWFBIbWtJVXlPOUtzRHZEbXRfM2ducE1TMGRTX0dGMUtuM05EeERPb2p3U0N5OHhzaktTaTQxRTlUc1hncEtzYUZZUUI2SnY?oc=5\" target=\"_blank\">Enlaza Therapeutics Forms $2.4 Billion Collaboration with Vertex Pharmaceuticals</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">PharmExec</font>",
      "published": "2025-09-03T18:12:36+00:00",
      "source": "PharmExec"
    },
    {
      "title": "Enlaza Therapeutics Announces Strategic Collaboration with Vertex Pharmaceuticals to Develop War-Lock Drug Conjugates and T-Cell Engagers for Improved Conditioning and Certain Autoimmune Diseases - Business Wire",
      "link": "https://news.google.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?oc=5",
      "summary": "<a href=\"https://news.google.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?oc=5\" target=\"_blank\">Enlaza Therapeutics Announces Strategic Collaboration with Vertex Pharmaceuticals to Develop War-Lock Drug Conjugates and T-Cell Engagers for Improved Conditioning and Certain Autoimmune Diseases</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Business Wire</font>",
      "published": "2025-09-02T13:00:00+00:00",
      "source": "Business Wire"
    },
    {
      "title": "Vertex Pharma CEO Buys the Stock Dip - Barron's",
      "link": "https://news.google.com/rss/articles/CBMic0FVX3lxTE1FQVJjT2c1VUFSWUwwV0FtZGx1cW9kaVJ3SWctVUxmVjQ5Mm5IUzI4UzY1ZkdLbnJTRWNLTTFZN09Nc3FVanM0RkRIZVNLMkZ6Uk1JS0pxVk1BNFVHT0VYY08tbThSeGJmNTVFYnBhZ0MzcFk?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMic0FVX3lxTE1FQVJjT2c1VUFSWUwwV0FtZGx1cW9kaVJ3SWctVUxmVjQ5Mm5IUzI4UzY1ZkdLbnJTRWNLTTFZN09Nc3FVanM0RkRIZVNLMkZ6Uk1JS0pxVk1BNFVHT0VYY08tbThSeGJmNTVFYnBhZ0MzcFk?oc=5\" target=\"_blank\">Vertex Pharma CEO Buys the Stock Dip</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Barron's</font>",
      "published": "2025-08-15T07:00:00+00:00",
      "source": "Barron's"
    },
    {
      "title": "Vertex forges $2B-plus alliance with Enlaza to create new autoimmune drugs, improve conditioning methods - Fierce Biotech",
      "link": "https://news.google.com/rss/articles/CBMixgFBVV95cUxNMDh5TXBVdVRQaUU2ZE1pal85SW5pTktsX1ViODNxOTNfbzItRTQtWGhKcHlyU3ZWMHVzWmxueWhXNFJ0cnNIeXNhU3NsaVM0VjFQUmtLYkV1VXR5OUFtTk95NDVPb2F6SjYzY1hrRVpld3lVNXZnQTN4bld6S0Fiem9wUlhuaS02NVZXWUVuZkVnX1QxbkRCVHFJVlFUZU0xUVpWcUJKRWM0ZzYzMEFsaEhFNC13N0xzUXhlUkFISG9MTDVBbmc?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMixgFBVV95cUxNMDh5TXBVdVRQaUU2ZE1pal85SW5pTktsX1ViODNxOTNfbzItRTQtWGhKcHlyU3ZWMHVzWmxueWhXNFJ0cnNIeXNhU3NsaVM0VjFQUmtLYkV1VXR5OUFtTk95NDVPb2F6SjYzY1hrRVpld3lVNXZnQTN4bld6S0Fiem9wUlhuaS02NVZXWUVuZkVnX1QxbkRCVHFJVlFUZU0xUVpWcUJKRWM0ZzYzMEFsaEhFNC13N0xzUXhlUkFISG9MTDVBbmc?oc=5\" target=\"_blank\">Vertex forges $2B-plus alliance with Enlaza to create new autoimmune drugs, improve conditioning methods</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Fierce Biotech</font>",
      "published": "2025-09-02T14:26:00+00:00",
      "source": "Fierce Biotech"
    },
    {
      "title": "Vertex Pharmaceuticals Incorporated (VRTX) Slid on Softer Revenue and Earnings - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMilgFBVV95cUxNT0lYbXJoajkyY2EtQUVyU1g3al9vMk05Y0txbHBVWUdwM0pURWsyRGhXWVJ3OWVVYTNybmFxbnFCV2UwV0FaR05leElvNi13ZC1IZnRhdjJLRWlWSGtnMENvQUI4Wm5IdF9iMUw3S0x1dFBaZ3ZvajZFMXlsTGxnRVJVUW5vQWJIYl9VcE56MGlOTmhoM0E?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMilgFBVV95cUxNT0lYbXJoajkyY2EtQUVyU1g3al9vMk05Y0txbHBVWUdwM0pURWsyRGhXWVJ3OWVVYTNybmFxbnFCV2UwV0FaR05leElvNi13ZC1IZnRhdjJLRWlWSGtnMENvQUI4Wm5IdF9iMUw3S0x1dFBaZ3ZvajZFMXlsTGxnRVJVUW5vQWJIYl9VcE56MGlOTmhoM0E?oc=5\" target=\"_blank\">Vertex Pharmaceuticals Incorporated (VRTX) Slid on Softer Revenue and Earnings</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-09-02T13:25:28+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Stock Analysis | Vertex Pharmaceuticals Outlook - Mixed Signals and Volatility Ahead - AInvest",
      "link": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxNNjVJelZLMVNXUWNTRGxZX2ZMTjlzQzd5VmQwZlA4MHAwUFFLQUxyTEJqVUZyM1dIcXktR2J1WXRfbFRWaTRzeGtzV3daOWRGczJBaHQ1TWxPMTA1dXZQQ3VvazVvQV9ua3JlakFOVjY2ck9sckxLbTBydUJqVlljdlM4TE5JSjFta3I0X0wwOHd6VkE0bGZISkEyRXRDWWdzbTlhYjg4ZE8?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiqAFBVV95cUxNNjVJelZLMVNXUWNTRGxZX2ZMTjlzQzd5VmQwZlA4MHAwUFFLQUxyTEJqVUZyM1dIcXktR2J1WXRfbFRWaTRzeGtzV3daOWRGczJBaHQ1TWxPMTA1dXZQQ3VvazVvQV9ua3JlakFOVjY2ck9sckxLbTBydUJqVlljdlM4TE5JSjFta3I0X0wwOHd6VkE0bGZISkEyRXRDWWdzbTlhYjg4ZE8?oc=5\" target=\"_blank\">Stock Analysis | Vertex Pharmaceuticals Outlook - Mixed Signals and Volatility Ahead</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">AInvest</font>",
      "published": "2025-09-04T03:29:23+00:00",
      "source": "AInvest"
    },
    {
      "title": "Vertex Pharma, Enlaza sign R&D pact worth up to $2B plus equity - Seeking Alpha",
      "link": "https://news.google.com/rss/articles/CBMihwFBVV95cUxNYTNLdDRjazJVWWRWblpkREJWczB1dDlrb211Vl9NUkNBWXdDVVg1RWs5Uk43Ti1lSzgtMi1Za1RHajd6R3otdW14d1pMcDBlMmxwdjl2N3B6V1U3VzZZLTRnZW9Ea01OY3ptZnQ4dWNWUm5NTmlFejZLb3hKajBYNUVBZjdvRGc?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMihwFBVV95cUxNYTNLdDRjazJVWWRWblpkREJWczB1dDlrb211Vl9NUkNBWXdDVVg1RWs5Uk43Ti1lSzgtMi1Za1RHajd6R3otdW14d1pMcDBlMmxwdjl2N3B6V1U3VzZZLTRnZW9Ea01OY3ptZnQ4dWNWUm5NTmlFejZLb3hKajBYNUVBZjdvRGc?oc=5\" target=\"_blank\">Vertex Pharma, Enlaza sign R&amp;D pact worth up to $2B plus equity</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>",
      "published": "2025-09-02T14:39:35+00:00",
      "source": "Seeking Alpha"
    }
  ],
  "product_launches": [
    {
      "title": "Strong Product Launches and Upbeat Guidance Could Be a Game Changer for Vertex Pharmaceuticals (VRTX) - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMijgFBVV95cUxNOFZFNHZzSk1rSnJWVTEwWExLd1FvWVBPUkVkTV9TRG1oUWdTbWgzbWNkdlA3MkVLNmVra3NUUWhBQWFXZ3c5LVNxZFRkWDhkMUZ1QVlUXzg3ZEZwOHY3TTRjMEYxUjlwZFhYVW84QUVXX0lQaTZVbDN4Qk5WM1NQX0EwSVJXZ2piZXl4d3ZB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMijgFBVV95cUxNOFZFNHZzSk1rSnJWVTEwWExLd1FvWVBPUkVkTV9TRG1oUWdTbWgzbWNkdlA3MkVLNmVra3NUUWhBQWFXZ3c5LVNxZFRkWDhkMUZ1QVlUXzg3ZEZwOHY3TTRjMEYxUjlwZFhYVW84QUVXX0lQaTZVbDN4Qk5WM1NQX0EwSVJXZ2piZXl4d3ZB?oc=5\" target=\"_blank\">Strong Product Launches and Upbeat Guidance Could Be a Game Changer for Vertex Pharmaceuticals (VRTX)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-08-22T07:00:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Vertex Pharmaceuticals' Q2 Results: Robust Launches and Revenue Guidance - AInvest",
      "link": "https://news.google.com/rss/articles/CBMiowFBVV95cUxOTDdlM0tKUmUwRmRORXFhbWYxWVZOY2dTaXJVMDVwdHBua3Rsd0sxUFo0UDVhTDRPXzZjTjFtZ1Q2Nl9jYWVWZ203OGhXb21hWnoyWkpHWXBZUUgzLUUzRmttRkcwelhZMEd1ekk0NVlfa1JXNXhqRnV1U1ZJWkZGTU9rcEozWXN3SFRMeUI2U0l2UTVrN1hubmdkTjBGZXU0eEpF?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiowFBVV95cUxOTDdlM0tKUmUwRmRORXFhbWYxWVZOY2dTaXJVMDVwdHBua3Rsd0sxUFo0UDVhTDRPXzZjTjFtZ1Q2Nl9jYWVWZ203OGhXb21hWnoyWkpHWXBZUUgzLUUzRmttRkcwelhZMEd1ekk0NVlfa1JXNXhqRnV1U1ZJWkZGTU9rcEozWXN3SFRMeUI2U0l2UTVrN1hubmdkTjBGZXU0eEpF?oc=5\" target=\"_blank\">Vertex Pharmaceuticals' Q2 Results: Robust Launches and Revenue Guidance</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">AInvest</font>",
      "published": "2025-08-22T07:00:00+00:00",
      "source": "AInvest"
    },
    {
      "title": "Vertex Pharmaceuticals: Promising Growth with Successful Launch and Strong Pipeline - TipRanks",
      "link": "https://news.google.com/rss/articles/CBMixwFBVV95cUxQWEN0dzJBekJiaFJYMm9qbVN5Q3djdThMV0VTSlI2aDRDSDM2ZHhCOHI5N3BxTzRMcnVRVzNBM05Sc21acGdKcXRhM01XTkdNT1QyLVRpWmFiMkJKb1lOZkxzMlBnbHFWbzAzUXdPNTBncG9ReGlkLXBMaFNIc1NRSTV1UjRxcUFmQ0RiTl9RUjJFdU9jQ0V0Si0wdW9mQ01ITWo1WVhzbUhEV253dmh4LVI0TnJvZ3BCVWNfNFFDVXowc0xvdU8w?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMixwFBVV95cUxQWEN0dzJBekJiaFJYMm9qbVN5Q3djdThMV0VTSlI2aDRDSDM2ZHhCOHI5N3BxTzRMcnVRVzNBM05Sc21acGdKcXRhM01XTkdNT1QyLVRpWmFiMkJKb1lOZkxzMlBnbHFWbzAzUXdPNTBncG9ReGlkLXBMaFNIc1NRSTV1UjRxcUFmQ0RiTl9RUjJFdU9jQ0V0Si0wdW9mQ01ITWo1WVhzbUhEV253dmh4LVI0TnJvZ3BCVWNfNFFDVXowc0xvdU8w?oc=5\" target=\"_blank\">Vertex Pharmaceuticals: Promising Growth with Successful Launch and Strong Pipeline</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TipRanks</font>",
      "published": "2025-08-18T07:00:00+00:00",
      "source": "TipRanks"
    },
    {
      "title": "Vertex tops estimates on cystic fibrosis treatment strength, new products - Reuters",
      "link": "https://news.google.com/rss/articles/CBMi2AFBVV95cUxQV1RfcWFhZlB4RnlGTUNfYlJTOEFKaHREZHlEeV9GVHpnaW1zRDliVlMtX3dWdjZkS2RNRWhZaXc0NmdVcW10bVhmQV9NNlh3b3IwckhEME9rTFlIci1hRDF4RlFzRWprOWFTdjlVV1d4dVpIaVFGWXBiWF9tbnJmcFEydUxiNDF1TVJfLTI4QmtvcnIwWVhYd3hNTno2aFhpZF9WNFZjX3lJLVVsNjZfcWZOVTVzU2lXYzV1cmw0bDRpTUFiWjJLUElvRk15d1RKLWJnQy10MmU?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi2AFBVV95cUxQV1RfcWFhZlB4RnlGTUNfYlJTOEFKaHREZHlEeV9GVHpnaW1zRDliVlMtX3dWdjZkS2RNRWhZaXc0NmdVcW10bVhmQV9NNlh3b3IwckhEME9rTFlIci1hRDF4RlFzRWprOWFTdjlVV1d4dVpIaVFGWXBiWF9tbnJmcFEydUxiNDF1TVJfLTI4QmtvcnIwWVhYd3hNTno2aFhpZF9WNFZjX3lJLVVsNjZfcWZOVTVzU2lXYzV1cmw0bDRpTUFiWjJLUElvRk15d1RKLWJnQy10MmU?oc=5\" target=\"_blank\">Vertex tops estimates on cystic fibrosis treatment strength, new products</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Reuters</font>",
      "published": "2025-08-04T07:00:00+00:00",
      "source": "Reuters"
    },
    {
      "title": "(suzetrigine), a First-in-Class Treatment for Adults With Moderate-to-Severe Acute Pain - Vertex Pharmaceuticals Newsroom",
      "link": "https://news.google.com/rss/articles/CBMivgFBVV95cUxQNGhZSnljSUNJSGJ4SzNPVXdNeXNncWRyT1dUWVY2VDVxWDFhamJGQUtSWlhJLVVJMmhSQjROckJNemJGZVlkY3ZmR0ZmYXBiX1J1ZHExdk1ZOW1wTWp5T1ZWa283c2RkYjdkUlgwMEtNejlNb3NJbVZJZlpyVmNweWptQ3dWeDAtV0NfVEJXNG5RU1pTZFRUY01hOEd0SXdwMXFTdEpGTnJTMklMX2NRUnBwUGhndjcyWUJzc0pn?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivgFBVV95cUxQNGhZSnljSUNJSGJ4SzNPVXdNeXNncWRyT1dUWVY2VDVxWDFhamJGQUtSWlhJLVVJMmhSQjROckJNemJGZVlkY3ZmR0ZmYXBiX1J1ZHExdk1ZOW1wTWp5T1ZWa283c2RkYjdkUlgwMEtNejlNb3NJbVZJZlpyVmNweWptQ3dWeDAtV0NfVEJXNG5RU1pTZFRUY01hOEd0SXdwMXFTdEpGTnJTMklMX2NRUnBwUGhndjcyWUJzc0pn?oc=5\" target=\"_blank\">(suzetrigine), a First-in-Class Treatment for Adults With Moderate-to-Severe Acute Pain</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Vertex Pharmaceuticals Newsroom</font>",
      "published": "2025-01-30T08:00:00+00:00",
      "source": "Vertex Pharmaceuticals Newsroom"
    }
  ],
  "stock": {
    "ticker": "VRTX",
    "currency": "USD",
    "latest": {
      "date": "2025-09-03",
      "close": 396.6199951171875
    },
    "history": [
      {
        "date": "2025-08-25",
        "close": 388.94000244140625
      },
      {
        "date": "2025-08-26",
        "close": 387.17999267578125
      },
      {
        "date": "2025-08-27",
        "close": 389.0799865722656
      },
      {
        "date": "2025-08-28",
        "close": 392.04998779296875
      },
      {
        "date": "2025-08-29",
        "close": 391.0199890136719
      },
      {
        "date": "2025-09-02",
        "close": 401.0
      },
      {
        "date": "2025-09-03",
        "close": 396.6199951171875
      }
    ],
    "name": "Vertex Pharmaceuticals Incorpor"
  }
}